Mucous Phlegming and his Sully Derangement Syndrome. Focus that Forehead on passing your Ferring modules (and moderating this board).
LOL.... you expect rankings at Azurity! How they rank changed several times last year. Nobody knows what it will be by Q4.
Yeah a 505 b2 with the same label as the innovator charging brand pricing through an LDD model is going to be a glorious failures
It’s surprising that SFM hasn’t tried to get rid of SE yet. I’m sure her narcissistic, jealous nature can’t stand how much SE is loved
Lilly will be launching Orforglipron next year, and Retatrutide in 2027, so the idea of layoffs when there are two drug launches on the horizon is much more "comical"..